Intramuscular Injection of Autologous Serum in Adolescent and Adult Patients with Atopic Dermatitis: A Preliminary Randomized Clinical Trial
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: The favorable clinical efficacies of intramuscular injection of autologous blood in patients with atopic dermatitis (AD) and intramuscular injection of autologous serum in patients with chronic urticaria have been demonstrated by randomized clini cal trials. In this study, we assessed the clinical effectiveness and safety of the intramuscular injection of autologous serum in pa tients with AD. Materials and Methods: In this randomized, placebo-controlled, and double-blind trial, 23 adolescent and adult patients with moderate-to-severe AD were enrolled. The patients were randomized to receive eight intramuscular injections of 5 mL of autolo gous serum (n=11) or saline (n=12) over 4 weeks, and were followed up until week 8. Changes in the clinical severity scores of AD assessed by SCORing Atopic Dermatitis (SCORAD), patient-reported Dermatology Life Quality Index (DLQI) score, and inci dence of adverse events were assessed from baseline to week 8. Results: One patient in the treatment group and two patients in the placebo group were lost to follow-up before week 8. The intra muscular administration of autologous serum, compared with saline, decreased the SCORAD clinical severity score (-14.8% vs. 10.7%, p=0.006) and improved the DLQI score (-32.6% vs. 19.5%, p=0.01) from baseline to week 8. Serious adverse events were not observed. Conclusion: Intramuscular injection of autologous serum may be effective in treating AD. Further studies are needed to evaluate the clinical usefulness of this intervention for AD (KCT0001969).
Abstract
Purpose: The favorable clinical efficacies of intramuscular injection of autologous blood in patients with atopic dermatitis (AD) and intramuscular injection of autologous serum in patients with chronic urticaria have been demonstrated by randomized clini cal trials. In this study, we assessed the clinical effectiveness and safety of the intramuscular injection of autologous serum in pa tients with AD. Materials and Methods: In this randomized, placebo-controlled, and double-blind trial, 23 adolescent and adult patients with moderate-to-severe AD were enrolled. The patients were randomized to receive eight intramuscular injections of 5 mL of autolo gous serum (n=11) or saline (n=12) over 4 weeks, and were followed up until week 8. Changes in the clinical severity scores of AD assessed by SCORing Atopic Dermatitis (SCORAD), patient-reported Dermatology Life Quality Index (DLQI) score, and inci dence of adverse events were assessed from baseline to week 8. Results: One patient in the treatment group and two patients in the placebo group were lost to follow-up before week 8. The intra muscular administration of autologous serum, compared with saline, decreased the SCORAD clinical severity score (-14.8% vs. 10.7%, p=0.006) and improved the DLQI score (-32.6% vs. 19.5%, p=0.01) from baseline to week 8. Serious adverse events were not observed. Conclusion: Intramuscular injection of autologous serum may be effective in treating AD. Further studies are needed to evaluate the clinical usefulness of this intervention for AD (KCT0001969).
참고문헌 (30)
- 남동호, "Personalized Immunomodulatory Therapy for Atopic Dermatitis: An Allergist’s View", Annals of Dermatology, 27(4), pp.355~363 (2015), 대한피부과학회
- Guttman-Yassky E, "New era of biologic therapeutics in atopic dermatitis", Expert Opin Biol Ther, 13, pp.549~561 (2013)
- Weidinger S, "Atopic dermatitis", Lancet, 387, pp.1109~1122 (2016)
- Beck LA, "Dupilumab treatment in adults with moderate-to-severe atopic dermatitis", N Engl J Med, 371, pp.130~139 (2014)
- Thaçi D, "Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments : a randomised, placebo-controlled, dose-ranging phase 2b trial", Lancet, 387, pp.40~52 (2016)
- Simpson EL, "Two phase 3 trials of dupilumab versus placebo in atopic dermatitis", N Engl J Med, 375, pp.2335~2348 (2016)
- Guttman-Yassky E, "Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis(measure up 1 and measure up 2) : results from two replicate double-blind, randomised controlled phase 3 trials", Lancet, 397, pp.2151~2168 (2021)
- Gottheil WS, "The autoserum treatment in dermatology", JAMA, 63, pp.1190~1194 (1914)
- Mori O, "Autologous whole blood intramuscular injection as a cure for chronic urticaria : report of a patient in whom intradermal injection of autologous serum continued to cause a weal-and-flare response", Br J Dermatol, 140, pp.1192~1193 (1999)
- Pittler MH, "Randomized, double-blind, placebo-controlled trial of autologous blood therapy for atopic dermatitis", Br J Dermatol, 148, pp.307~313 (2003)
- Debbarman P, "Autologous serum therapy in chronic urticaria : a promising complement to antihistamines", Indian J Dermatol, 59, pp.375~382 (2014)
- Staubach P, "Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test : a placebocontrolled trial", Dermatology, 212, pp.150~159 (2006)
- Schäfer T, "Alternative medicine in allergies-prevalence, patterns of use, and costs", Allergy, 57, pp.694~700 (2002)
- Hanifin JM, "Diagnostic features of atopic dermatitis", Acta Dermatol Venereol, 60(Supplement 92), pp.44~47 (1980)
- Konstantinou GN, "EAACI", GA(2)LEN task force consensus report : the autologous serum skin test in urticaria, 2009, pp.64, 1256~1268
- European Task Force on Atopic Dermatitis, "Severity scoring of atopic dermatitis : the SCORAD index : consensus report of the European Task Force on Atopic Dermatitis", Dermatology, 186, pp.23~31 (1993)
- Hanifin JM, "The eczema area and severity index(EASI) : assessment of reliability in atopic dermatitis", Exp Dermatol, 10, pp.11~18 (2001)
- Finlay AY, "Dermatology life quality index(DLQI)--a simple practical measure for routine clinical use", Clin Exp Dermatol, 19, pp.210~216 (1994)
- Futamura M, "A systematic review of investigator global assessment(IGA)in atopic dermatitis(AD)trials : many options, no standards", J Am Acad Dermatol, 74, pp.288~294 (2016)
- Jeon IK, "Three cases of pruritic urticarial papules and plaques of pregnancy(PUPPP)treated with intramuscular injection of autologous whole blood", J Eur Acad Dermatol Venereol, 29, pp.797~800 (2015)
- Zhao B, "Successfully treated recalcitrant atopic eczema with acupoint autohemotherapy : a case report and hypothesized mechanism of the therapy", J Integr Med, 20, pp.182~186 (2022)
- Chopra R, "Assessing the severity of atopic dermatitis in clinical trials and practice", Clin Dermatol, 36, pp.606~615 (2018)
- Langer SS, "Efficacy of house dust mite sublingual immunotherapy in patients with atopic dermatitis : a randomized, double-blind, placebo-controlled trial", J Allergy Clin Immunol Pract, 10, pp.539~549 (2022)
- Katoh N, "A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan(rising up) : an interim 24-week analysis", JAAD Int, 6, pp.27~36 (2022)
- Guttman-Yassky E, "Upadacitinib in adults with moderate to severe atopic dermatitis : 16-week results from a randomized, placebo-controlled trial", J Allergy Clin Immunol, 145, pp.877~884 (2020)
- Bajaj AK, "Autologous serum therapy in chronic urticaria : old wine in a new bottle", Indian J Dermatol Venereol Leprol, 74, pp.109~113 (2008)
- 남동호, "Autologous Immunoglobulin Therapy in Patients With Severe Recalcitrant Atopic Dermatitis: A Preliminary Report", Allergy, Asthma & Immunology Research, 6(1), pp.89~94 (2014), 대한천식알레르기학회
- Abdolkarim Sheikhi, "Autohemotherapy in Chronic Urticaria: What Could Be the Autoreactive Factors and Curative Mechanisms?", Annals of Dermatology, 26(4), pp.526~527 (2014), 대한피부과학회
- 남동호, "Efficacy, Safety, and Immunomodulatory Effect of the Intramuscular Administration of Autologous Total Immunoglobulin G for Atopic Dermatitis: A Randomized Clinical Trial", Allergy, Asthma & Immunology Research, 12(6), pp.949~963 (2020), 대한천식알레르기학회[DOI]
- Kwon B, "Intramuscular administration of autologous total immunoglobulin G induces immunomodulatory effects on T cells in healthy human subjects : an open-labeled prospective single-arm trial", Medicine(Baltimore), 101, pp.e29486~ (2022)